Decold

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Decold

Property Description
Active Ingredient Amantadine Hydrochloride
Form Oral Solid Forms (Tablets/Capsules) or Oral Solution
Pharmacological Class Antiviral Drug and Antiparkinsonian Agent
General Purpose Managing specific viral infections and certain movement symptoms
Origin Synthetic Compound (Adamantane Derivative)

What Type of Medicine is Decold (Amantadine Hydrochloride)?

Decold is a brand name for a prescription-only medication whose active component is Amantadine Hydrochloride. This single-ingredient compound is distinguished by its unique dual classification, being designated both as an Antiviral drug and an Antiparkinsonian agent. This multifunctionality means the medicine is clinically recognized for addressing conditions in two separate therapeutic areas.

Amantadine is a synthetic compound derived from the complex ring structure known as Adamantane, a distinct chemical feature that informs its broad pharmacological capabilities. The formulation of the Decold brand utilizes this structure to target both adults and specific pediatric patient groups requiring systemic medication.

Composition and Available Forms of Decold

The Decold brand is a single active ingredient product, consisting of Amantadine Hydrochloride combined with pharmaceutical excipients necessary for stability and systemic delivery. The drug is consistently administered via the oral route of administration and is typically presented as high-level pharmaceutical forms, including Oral solid forms (such as Tablets or Capsules) and an Oral solution. These oral dosage forms ensure the reliable systemic action of the drug, allowing the compound to be absorbed and distributed throughout the body to exert its intended effects.

General Therapeutic Role of Amantadine

The general purpose of Amantadine Hydrochloride is derived from its two separate biological activities. Its core role as an Antiviral drug is specifically directed against the Influenza A virus, where it interferes with the viral M2 ion channel to disrupt replication. Separately, its function as an Antiparkinsonian agent involves acting as a mild dopaminergic agent and blocking the NMDA receptor, modulating chemical signals that influence movement. These dual actions confirm the drug's utility in both supporting neurological symptom management and providing targeted effect against a specific viral infection.

Regulatory References

  1. MedlinePlus

What side effects are possible with Decold?

The safety profile of Decold (Amantadine Hydrochloride) is defined by official regulatory documents, which classify adverse reactions based on their frequency and the body system affected.

Officially Documented Side Effects and Frequencies

The most commonly listed adverse reactions (classified as Common or Very Common) are linked to the Central Nervous System and peripheral systems. These include livedo reticularis (a lace-like skin discoloration), peripheral oedema, dry mouth, constipation, and hallucinations.

Reactions are grouped by system-organ class in regulatory labeling, with notable involvement in Nervous System (e.g., dizziness, insomnia, ataxia), Psychiatric (e.g., depression, confusion), Gastrointestinal (e.g., nausea), and Cardiac (e.g., palpitations) disorders.

Serious Adverse Reactions and Safety Constraints

The label documents several serious reactions, including Neuroleptic Malignant Syndrome (NMS)-like symptoms reported upon abrupt withdrawal or rapid dose reduction, seizure, cardiac arrest, and the potential for suicidal ideation.

Safety notes specify that adverse effects, particularly those affecting the CNS, may be more pronounced at the beginning of treatment or following dose increases.

Population-Specific Safety Considerations

Safety is significantly related to renal function. The drug is primarily cleared by the kidneys, necessitating dose adjustments for patients with renal impairment. The risk of CNS toxicity (confusion, hallucinations) is heightened in older adults. Furthermore, the drug should not be used in individuals with severe kidney disease or untreated angle-closure glaucoma.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose of Decold (Amantadine Hydrochloride) is officially documented in regulatory information to primarily affect the Central Nervous System and the Cardiovascular System.

Documented overdose presentations include severe neurological disturbances, such as acute psychosis, visual hallucinations, delirium, confusion, and life-threatening convulsions or seizures. Severe outcomes reported in regulatory documents include cardiac arrest, sudden cardiac death, malignant ventricular arrhythmias, and serious pulmonary complications (e.g., pulmonary edema, ARDS).

Immediate Medical Attention Required

Any suspected overdose is an emergency requiring immediate medical attention. Emergency services (911 or equivalent) must be contacted immediately if a person exhibits a seizure, has trouble breathing, collapses, or cannot be awakened.

Overdose Management Focus Official Regulatory Statement
Antidote Status No specific antidote is known. Management is purely symptomatic and supportive.
Required Monitoring ECG monitoring is required. Observation must continue for at least 8–12 hours after acute ingestion.
Special Risk Patients with renal insufficiency are at increased risk of toxicity, even due to therapeutic doses, due to reduced drug elimination.

Therapeutic Uses of Decold

What Decold Treats: Main Uses and Benefits

Decold (Amantadine Hydrochloride) is used across two distinct therapeutic domains, generally providing symptomatic relief from movement disorders and supportive benefit during a specific viral illness. This clinical profile encompasses its recognized therapeutic applications.


Relief from Involuntary Movements and Parkinsonian Symptoms

This domain covers the medication's use in managing symptoms of increased neurological or muscular activity, relevant for adults with Parkinson's Disease. It is commonly used to help with managing certain noticeable symptoms, such as rigidity, bradykinesia (slowness), and problematic dyskinesia (uncontrolled movements) associated with certain therapeutic regimens. Decold provides support that helps ease the overall symptom burden, and assists with maintaining functional stability. It is also used in situations involving movement difficulties associated with certain prescription drugs.

Quick Fact: Relief for Involuntary Movements (Dyskinesia)


Symptomatic Support for Acute Influenza A

Decold is also applied across domains where additional symptomatic support is needed for illness caused by the Influenza A virus. It is relevant when symptoms become more noticeable, such as fever and muscle aches, which can create noticeable physiological strain. This therapeutic approach is relevant for easing the impact of acute manifestations; it offers symptomatic relief that helps patients cope with difficult episodes, supporting general well-being during symptomatic phases.


The medication is applied across two primary therapeutic areas: Parkinson's disease and associated drug-induced extrapyramidal reactions, and illness caused by the Influenza A virus.

Regulatory References

  1. NIH StatPearls on Amantadine

Eligibility and Restrictions for Use

Who Can and Cannot Use Decold? (Official Regulatory Information)

Official regulatory documents define strict eligibility criteria for Decold, a multi-component cold relief medicine, primarily based on contraindications, age, and existing health conditions.

Absolute Prohibitions (Contraindications)

Decold is strictly prohibited for use in individuals with:

  • Known Hypersensitivity (allergy) to any of its active components (e.g., paracetamol, phenylephrine).
  • Severe Liver Impairment or Severe Hypertension.
  • Serious Heart Conditions or Cardiovascular Disorders.
  • Concurrent or recent use (within 14 days) of Monoamine Oxidase Inhibitors (MAOIs).

Restricted and Conditional Use

The medicine is generally intended for adults and adolescents (typically 12 years and older). Use in young children is limited or prohibited below specific age cut-offs, varying by regulatory region.

Special caution and supervision are required for patients with:

  • Mild-to-moderate renal or hepatic impairment (dose adjustments may be necessary).
  • Diabetes Mellitus or Glaucoma.

Pregnancy and Lactation Status

Use is generally not recommended during pregnancy or breastfeeding due to insufficient safety data or the potential for components to pass into breast milk, as stated in official labeling.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section details officially documented drug and product interactions for Decold, based on authoritative government regulatory information.


Contraindicated Combinations and Major Restrictions

Co-administration of Decold with Monoamine Oxidase Inhibitors (MAOIs) is strictly forbidden due to the risk of serious, potentially fatal reactions. A mandatory washout period of at least 14 days is required after stopping an MAOI before starting Decold, and vice versa. Additionally, the concurrent use of any other medicinal product containing acetaminophen is contraindicated to avoid exceeding maximum daily limits and prevent severe hepatotoxicity.


Clinically Significant Interactions

  • Pharmacodynamic Effects: The use of Decold with alcohol or other Central Nervous System (CNS) Depressants (e.g., sedatives, muscle relaxants) is officially cautioned against. This combination can result in additive effects, significantly increasing drowsiness and impairment.
  • Metabolic and Exposure Modification: Decold is subject to interactions involving the Cytochrome P450 (CYP) 2D6 enzyme and certain P-glycoprotein (P-gp) inhibitors. Co-administration with strong CYP2D6 inhibitors (e.g., quinidine) may significantly increase Decold's systemic exposure, potentially raising the risk of toxicity. Herbal products, such as St. John's wort, may also modify exposure.

Population-Specific Notes

Specific warnings regarding hepatotoxicity risk are documented for patients with pre-existing liver disease or chronic heavy alcohol consumption, primarily concerning the acetaminophen component of Decold.

Mechanism of Action

The mechanism of action for Decold (Amantadine Hydrochloride) involves two distinct, independent pharmacological activities: direct antiviral action targeting a specific viral protein, and complex neuromodulation of key pathways in the central nervous system.


M2 Ion Channel Blockade and Viral Uncoating Inhibition

This mechanism involves physically blocking the M2 ion channel protein, which is essential for the Influenza A virus to complete the process of uncoating within the host cell. This targeted blockade prevents the viral genome from being released into the cytoplasm, thereby suppressing the initiation of viral replication, resulting in reduced formation of new viral particles.


Dual Modulation of Dopaminergic and Glutamatergic Systems

This domain covers the drug's effects within the central nervous system. Amantadine acts to increase the synaptic concentration of dopamine by promoting its release and inhibiting its reuptake via the Dopamine Transporter. Simultaneously, it functions as a non-competitive antagonist at the NMDA receptor, thereby reducing the overall excitatory neural output. These coordinated actions modulate the neurochemical balance in the striatum, altering the neural output governing motor control.

Dosage and Administration Information

How to Use Decold: Official Administration Guidelines

This section summarizes the standardized instructions for using this medicine.

Administration Feature Official Instruction
Route of Administration Oral
Dosing Rule Take in the exact dose and duration as prescribed by your doctor or as printed on the product label. Do not exceed the maximum prescribed dose.
Timing in Relation to Meals May be taken with or without food. Taking with food is recommended to help avoid stomach upset.
Preparation Requirements Swallow the tablet whole with sufficient water. Do not chew, crush, or break the tablet. For liquid forms, shake well before use and measure the dose accurately.
Duration of Use Do not take for longer than seven days unless specifically advised by a doctor.
Age-Group Rules The prescribed dose may need adjustment by a doctor for patients with liver disease.
Missed Dose If a dose is missed, take it as soon as you remember. If it is close to the next scheduled dose, skip the missed dose and continue your regular schedule. Do not take a double dose to compensate.

Procedural Context

Official instructions require the user to adhere strictly to the prescribed dose and frequency to maintain the medicine’s standardized therapeutic delivery. A key procedural step is the physical act of swallowing the tablet whole, which ensures the proper release and absorption of its active components. Furthermore, the instructions enforce an explicit maximum duration of use and mandate limitations on co-ingestion of certain substances like caffeine and alcohol. These rules define the standardized protocol for safe and correct use.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Decold

Evidence for use in Symptomatic Relief of the Common Cold

Research examining symptom changes related to the common cold primarily involves short-term, randomized, controlled clinical trials (RCTs). These studies have often explored the effects of the active components (such as the analgesic and decongestant ingredients) both individually and in various combinations. Researchers were mainly interested in outcomes related to physical discomfort, using standardized scales to track how symptoms evolved in the observed populations, particularly focusing on nasal congestion, headache, and general body aches.

The studies monitored changes related to systemic or functional imbalance, which is typically the first few days of the cold, during periods of increased symptom activity. Findings describe patterns observed in these studies where the groups receiving the active combination had different measured symptom score changes compared to control groups over the study intervals. This research contributes to the broader evidence landscape for conditions characterized by fluctuating or episodic manifestations, providing context for short-term changes that were observed.

Comparison with Placebo and Other Symptom Treatments

Similar component combinations were also evaluated in research exploring how symptoms change when compared against an inactive substance (placebo) or against other single-ingredient compounds used for cold symptom management. These studies were designed to measure changes related to episodic or acute symptoms. Research examined how patient-reported outcomes describing perceived discomfort differed between those receiving the combination and those in the comparator groups.

Long-Term Studies and Follow-up Duration

Research on Decold is primarily relevant in trials assessing short-term or episodic symptom patterns, as the common cold is generally a self-limiting condition lasting only a short time. Therefore, the follow-up durations were limited, typically spanning only the acute symptomatic phase. There is limited information for long-term outcomes related to the use of Decold, and long-term effects are not fully established.

Research Gaps and Remaining Uncertainties about Decold

Certain essential areas remain uncertain. Follow-up durations were limited across most trials, leaving long-term outcomes not fully established. Similarly, comparative evidence is lacking when attempting to directly assess the exact four-ingredient combination against all other similar cold remedies on the market. Furthermore, sample sizes were modest in some studies, and data for special groups—such as those with multiple underlying health issues—remain insufficient. Research provides context but not individual predictions, and the evidence highlights what is known—and what is still uncertain.

Frequently Asked Questions (FAQ)

Common questions about Decold (FAQ)


Q: How quickly should I expect to feel relief after taking Decold?

A: Official information suggests that for influenza, treatment is typically started early in the course of the illness. For movement-related symptoms, some improvement may be noted in a few days, but the full benefit of the active ingredient may take longer to be observed.

Q: How long does the effect of a single dose of Decold typically last?

A: Regulatory information indicates that the drug's active component has a relatively long half-life in healthy adults, meaning it stays in the body for an extended period. Healthcare providers determine appropriate dosing intervals based on this pharmacokinetic profile, rather than a short duration of symptomatic relief.

Q: What are the most commonly reported, less serious side effects of Decold?

A: Commonly reported side effects, as noted in official documents, include dry mouth, constipation, nausea, and dizziness. Involvement in the nervous system, such as confusion or insomnia, has also been reported.

Q: Can Decold cause stomach upset or nausea in some users?

A: Yes, nausea is a commonly reported side effect associated with the use of Decold, according to official safety documents. The drug may also be associated with other mild gastrointestinal issues or decreased appetite in some individuals.

Q: Can Decold affect sleep patterns, even if it's not the 'nighttime' formula?

A: Official safety information indicates that the active ingredient has been associated with effects on sleep patterns. Insomnia (difficulty sleeping) is listed as a commonly reported nervous system effect. Conversely, some individuals have also reported drowsiness or excessive sleepiness.

Q: Are there any specific herbal supplements that should be avoided while using Decold?

A: Official labels emphasize that strong CYP2D6 inhibitors, such as the herbal supplement St. John’s wort, may interact with this medication and potentially modify its systemic exposure. Always consult with a healthcare professional regarding all supplements or products being used.

Q: Can I safely drive or operate machinery after taking Decold?

A: The official label cautions that due to potential side effects like dizziness, confusion, or blurred vision, patients should avoid driving or operating heavy machinery until they understand the medication's full effect on them.

Q: What should I do if Decold doesn't seem to be working after a couple of days?

A: Official instructions specify that this medication is intended to be taken for the full duration prescribed. If symptoms worsen or persist despite taking the medication as directed, official guidelines suggest contacting a healthcare professional for further evaluation.

Q: Does Decold have a reputation for causing confusion or 'fogginess'?

A: Official safety documents list confusion as a reported psychiatric side effect. More serious mental status changes, including disorientation or hallucinations, have also been reported. Individuals should report any feelings of 'fogginess' or mental changes to their healthcare provider.

Q: Can Decold be taken with acid reflux medication?

A: The clearance of the active ingredient from the body can be affected by medications that change the pH of the urine. Because antacids or acid reflux medications may potentially affect this, combining them with Decold should only be done under the guidance of a healthcare professional.

Q: Is Decold considered an over-the-counter (OTC) medication or prescription-only?

A: Regulatory sources clearly classify Amantadine Hydrochloride, the active ingredient in Decold, as a prescription-only medication. It requires authorization from a licensed healthcare professional to be dispensed.

Q: What types of cold and flu symptoms is Decold specifically formulated to treat?

A: The active ingredient in Decold, Amantadine, is indicated for the prevention and treatment of illness caused by the Influenza A virus. It is important to note that it is not officially indicated for use against the common cold or other types of flu viruses.

Q: Can Decold be taken to help with seasonal allergies, or is it only for colds?

A: Official regulatory documents specify the indications for Decold's active ingredient. Its established uses are restricted to the management of Influenza A virus and certain movement disorders; it is not indicated for the treatment of seasonal allergies.

Q: Is Decold safe for teenagers to take for a cold?

A: Official safety information notes that the safety and effectiveness of the active ingredient have not been established across all pediatric populations. Therefore, the use of this medication in adolescents and children requires supervision and management by a healthcare professional.

Q: What happens if I accidentally take Decold too close to another dose?

A: Taking doses too closely together may increase the risk of drug toxicity or an overdose. The official guidance for overdose (which includes symptoms like heart rhythm changes and confusion) should prompt immediate contact with emergency medical services if a dose timing error is suspected.

Q: Is there any research supporting the effectiveness of Decold's combination of ingredients?

A: Studies on the active ingredient, Amantadine, indicate that it can be effective in decreasing the severity of symptoms associated with the Influenza A virus. Research suggests it can also help reduce the severity of related symptoms such as fever.

Q: Has Decold been studied in populations with mild chronic conditions?

A: Official warnings and cautions are provided regarding the use of Decold in patients with pre-existing conditions such as kidney, liver, and heart problems. A healthcare provider must evaluate the suitability of the medication for any patient with chronic health issues.

Q: Can I take Decold if I have a history of mild high blood pressure?

A: Because the active ingredient has been associated with elevated blood pressure, and overdose can cause hypertension, individuals with a history of high blood pressure are typically monitored by a healthcare professional during treatment.

Q: Is it normal to feel a little jittery after taking Decold?

A: The official product information notes that psychiatric side effects can include agitation, nervousness, and anxiety. Any such reaction, including a feeling of 'jitteriness,' should be brought to the attention of a healthcare professional.

Q: Is Decold generally safe for people who have diabetes?

A: As with any prescription drug, a healthcare provider must evaluate the suitability and safety of the medication for any patient who has pre-existing conditions, including diabetes, before treatment is initiated.

Q: Does Decold contain any dyes or common allergens like gluten?

A: According to the official description, the tablet formulation contains FD&C Yellow No. 6, and the syrup form may contain common pharmaceutical additives like methylparaben and artificial flavorings. Patients with known allergies should always review the full list of inactive ingredients on the label.

Q: What is the average shelf life of a package of Decold once it's opened?

A: The drug must be stored at controlled room temperature and protected from heat and moisture. For liquid forms, the dispensing pharmacist may assign a specific Beyond-Use Date (BUD) after the container is opened, which may override the original expiration date.

Q: Is Decold known to interfere with the effectiveness of birth control pills?

A: The official label suggests that women of child-bearing age consider using highly effective non-hormonal contraception during and for a period after treatment with this medication. Specific advice regarding contraception should be addressed with a healthcare provider.

Q: Is there a generic version of Decold that works the same way?

A: Yes, official drug determinations indicate that the active ingredient in Decold, Amantadine Hydrochloride, is available in generic form. Generic versions contain the same active component and are required to meet the same standards for quality and effectiveness as the branded drug.

How should Decold be stored and disposed of?

Storage and Disposal of Decold (Amantadine Hydrochloride)

Decold must be stored at controlled room temperature, typically 20 C to 25 C (68 F to 77 F), and should be protected from excessive heat, light, and moisture.

Storage Requirements

  • Store the medicine in its original container and ensure the cap or closure is tightly closed.
  • It is mandatory to store Decold out of the sight and reach of children and pets, following official child-safety requirements.
  • The product must not be frozen; this is especially critical for the oral solution, which may also require disposal after a defined period post-opening.

Disposal Instructions

Unused or expired Decold must be disposed of safely. The required method is to use a drug take-back program. If a take-back site is unavailable, the product should be mixed with an unappealing substance, placed in a sealed container, and discarded in the household trash. The medicine must not be disposed of in the toilet or down any drain to prevent environmental release.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Decold found in:

A-Z Index: